Search results for "pic"

showing 10 items of 8215 documents

Appendectomy during the COVID-19 pandemic in Italy: a multicenter ambispective cohort study by the Italian Society of Endoscopic Surgery and new tech…

2021

AbstractMajor surgical societies advised using non-operative management of appendicitis and suggested against laparoscopy during the COVID-19 pandemic. The hypothesis is that a significant reduction in the number of emergent appendectomies was observed during the pandemic, restricted to complex cases. The study aimed to analyse emergent surgical appendectomies during pandemic on a national basis and compare it to the same period of the previous year. This is a multicentre, retrospective, observational study investigating the outcomes of patients undergoing emergent appendectomy in March–April 2019 vs March–April 2020. The primary outcome was the number of appendectomies performed, classifie…

medicine.medical_specialtyCOVID-19 PandemicCoronavirus disease 2019 (COVID-19)Endoscopic surgeryNOAppendectomy; Appendicitis; COVID-19 Pandemic; Machine learningCohort Studies03 medical and health sciences0302 clinical medicinePostoperative ComplicationsRetrospective StudiePandemicMachine learningmedicineHumansAppendectomyAppendicitiLaparoscopyPandemicsRetrospective Studiesmedicine.diagnostic_testPandemicbusiness.industryCOVID-19 Pandemic Appendicitis Appendicectomy Machine learningSARS-CoV-2COVID-19Length of Staymedicine.diseaseAppendicitisAppendicitisSettore MED/18SurgeryItaly030220 oncology & carcinogenesisAppendectomy; appendicitis; COVID-19 pandemic; machine learning; appendectomy; cohort studies; humans; Italy; length of stay; pandemics; postoperative complications; retrospective studies; SARS-CoV-2; appendicitis; COVID-19; laparoscopy030211 gastroenterology & hepatologySurgeryObservational studyOriginal ArticleLaparoscopyPostoperative ComplicationAppendicectomyCohort StudiebusinessComplicationCohort studyHuman
researchProduct

Current status of implementation of self-administration training in various regions of Europe, Canada and the USA in the management of hereditary ang…

2013

Results from a 16-question survey about self-administration of hereditary angioedema (HAE) therapy, administered in Europe, Canada and the USA, were used to guide discussion at an international HAE expert meeting. The aim was to capture information about current practice in self-administered HAE therapy in these countries, including self-administration training, the key benefits of switching to self-administration, the barriers to self-administration and trends in self-administration. Overall, switching to self-administration therapy is looked upon favourably from both patient and clinician perspectives by virtue of the potential improvement in quality of life arising from optimisation of t…

medicine.medical_specialtyCanadaImmunologyMEDLINESelf AdministrationQuality of life (healthcare)Patient Education as TopicIntervention (counseling)Surveys and QuestionnairesmedicineImmunology and AllergyHumansProduct (category theory)business.industryAngioedemas HereditaryGeneral Medicinemedicine.diseaseUnited StatesEuropeCurrent practiceFamily medicineImmunologyHereditary angioedemaPhysical therapybusinessComplement C1 Inhibitor Protein
researchProduct

Gastric endoscopic features in portal hypertension: final report of a consensus conference, Milan, Italy, September 19, 1992.

1994

medicine.medical_specialtyCanadaMEDLINEIndiaEsophageal and Gastric VaricesJapanSurveys and QuestionnairesGastroscopyHypertension PortalmedicineHumansMulticenter Studies as TopicHepatologymedicine.diagnostic_testVascular diseasebusiness.industryGeneral surgeryConsensus conferencemedicine.diseaseUnited StatesEndoscopySurgeryEuropeItalyGastric MucosaPortal hypertensionbusinessJournal of hepatology
researchProduct

The impact of psychopharmacology on contemporary clinical psychiatry.

2014

Clinical psychiatric evaluations of patients have changed dramatically in recent decades. Both initial assessments and follow-up visits have become brief and superficial, focused on searching for categorical diagnostic criteria from checklists, with limited inquiry into patient-reported symptomatic status and tolerability of treatments. The virtually exclusive therapeutic task has become selecting a plausible psychotropic, usually based on expert consensus guidelines. These guidelines and practice patterns rest mainly on published monotherapy trials that may or may not be applicable to particular patients but are having a profound impact, not only on modern psychiatric practice but also on…

medicine.medical_specialtyCanadaQuality Assurance Health CarePsychopharmacologyAlternative medicineMEDLINEpsychiatric treatmentspsychiatric diagnosisclinical psychiatryPsychiatric educationMedicineHumansPractice Patterns Physicians'PsychiatryRandomized Controlled Trials as TopicPsychiatryClinical psychiatryPsychotropic DrugsPractice patternsbusiness.industryMental DisordersExpert consensusChecklistPsychiatry and Mental healthTreatment OutcomeTolerabilityIn ReviewPsychopharmacologyClinical CompetenceGuideline AdherencebusinessForecastingCanadian journal of psychiatry. Revue canadienne de psychiatrie
researchProduct

Ramucirumab in patients with previously treated advanced hepatocellular carcinoma: Impact of liver disease aetiology.

2021

BACKGROUND & AIMS Hepatocellular carcinoma (HCC) is a common complication of chronic liver disease with diverse underlying aetiologies. REACH/REACH-2 were global phase III studies investigating ramucirumab in advanced HCC (aHCC) following sorafenib treatment. We performed an exploratory analysis of outcomes by liver disease aetiology and baseline serum viral load. METHODS Meta-analysis was conducted in patients with aHCC and alpha-fetoprotein (AFP) ≥400 ng/mL (N = 542) from REACH/REACH-2 trials. Individual patient-level data were pooled with results reported by aetiology subgroup (hepatitis B [HBV] or C [HCV] and Other). Pre-treatment serum HBV DNA and HCV RNA were quantified using Roche CO…

medicine.medical_specialtyCarcinoma Hepatocellular610 Medizin610 Medicine & healthChronic liver diseaseAntibodies Monoclonal HumanizedGastroenterologyRamucirumab03 medical and health sciencesLiver disease0302 clinical medicine610 Medical sciencesInternal medicineMedicineHumans030304 developmental biology0303 health sciencesHepatologybusiness.industryLiver NeoplasmsHepatitis CHepatitis Bmedicine.diseasedigestive system diseases3. Good healthClinical Trials Phase III as Topic030220 oncology & carcinogenesisHepatocellular carcinomaLiver functionbusinessViral load
researchProduct

Screening and surveillance for hepatocellular carcinoma: perspective of a new era?

2016

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third most common cause of cancer-related death with an increasing prevalence worldwide. Early diagnosis of HCC is important since observational studies have reported that, in patients undergoing surveillance, cancer is diagnosed at an earlier stage with increased chances of curative therapies. Anyway, despite the extensive use of screening for HCC, its effectiveness is still a controversial topic since supporting evidence is not unequivocal and some issues need to be explored. Areas covered: The aim of this paper is to review main literature data supporting performance and effectiveness of screening for early detection …

medicine.medical_specialtyCarcinoma HepatocellularEarly detectionGastroenterology03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansMass ScreeningPharmacology (medical)In patientStage (cooking)Intensive care medicineCancer specific mortalityEarly Detection of CancerNeoplasm StagingRandomized Controlled Trials as Topicbusiness.industryLiver NeoplasmsCancermedicine.diseasedigestive system diseasesOncology030220 oncology & carcinogenesisHepatocellular carcinomaPopulation Surveillance030211 gastroenterology & hepatologyObservational studybusinessExpert review of anticancer therapy
researchProduct

Management of hepatitis C virus genotype 4: recommendations of an international expert panel.

2011

HCV has been classified into no fewer than six major genotypes and a series of subtypes. Each HCV genotype is unique with respect to its nucleotide sequence, geographic distribution, and response to therapy. Genotypes 1, 2, and 3 are common throughout North America and Europe. HCV genotype 4 (HCV-4) is common in the Middle East and in Africa, where it is responsible for more than 80% of HCV infections. It has recently spread to several European countries. HCV-4 is considered a major cause of chronic hepatitis, cirrhosis, hepatocellular carcinoma, and liver transplantation in these regions. Although HCV-4 is the cause of approximately 20% of the 170 million cases of chronic hepatitis C in th…

medicine.medical_specialtyCarcinoma HepatocellularGenotypeHepatitis C virusHepacivirusHepacivirusmedicine.disease_causeAntiviral AgentsPolymorphism Single NucleotideFlaviviridaeInternal medicineGenotypeEpidemiologyRibavirinmedicineHumansClinical Trials as TopicHepatologybiologybusiness.industryInterleukinsLiver Neoplasmsvirus diseasesHepatitis CHepatitis C Chronicbiology.organism_classificationmedicine.diseaseVirologydigestive system diseasesRecombinant ProteinsLiver TransplantationNatural historyHepatocellular carcinomaInterferon Type IPractice Guidelines as TopicHCVInterferonsbusiness
researchProduct

A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma.

2010

Knowing the spontaneous outcome of hepatocellular carcinoma (HCC) is important for designing randomized controlled trials (RCTs) of new therapeutic approaches; however, survival of patients in the absence of treatment is highly variable, and prognostic factors influencing outcomes are incompletely defined. The aims of this meta-analysis were to estimate the 1-year and 2-year survival rates of untreated HCC patients enrolled in RCTs of palliative treatments, and to identify prognostic factors. RCTs evaluating therapies for HCC with placebo or no-treatment arms were identified on MEDLINE through April 2009. Data were combined in a random effect model. Primary outcomes were 1-year and 2-year s…

medicine.medical_specialtyCarcinoma Hepatocellularlaw.inventionRandomized controlled triallawInternal medicinemedicineHumansChemoembolization TherapeuticSurvival rateNeoplasm StagingRandomized Controlled Trials as TopicHepatologyPerformance statusbusiness.industryLiver Neoplasmshepatocellular carcinomaHepatologymedicine.diseaseConfidence intervalSurgerySurvival RateMeta-analysisHepatocellular carcinomaRegression AnalysisLiver cancerbusinessPublication BiasHepatology (Baltimore, Md.)
researchProduct

"Pure" large cell neuroendocrine carcinoma of the gallbladder. Report of a case and review of the literature

2016

Primary Neuroendocrine Tumours (NETs) of the gallbladder are rare. Among all NETs of the gallbladder, large cell neuroendocrine carcinoma (LCNEC) is exceedingly rare. In most of the cases LCNECs are combined with other histological components. We reviewed clinical presentation and management of all patients with "pure" LCNEC from published literature since the first case was published in 2000, as well as one patient from our experience. Only 7 cases of "pure" LCNEC has been described in the last 15 years, our case is the eighth. The diagnosis of gallbladder NETs is rarely made preoperatively since the presentation generally consists of non-specific symptoms including upper abdominal pain, d…

medicine.medical_specialtyCarcinoma; Gallbladder; Large cell neuroendocrine carcinoma; Neuroendocrine carcinoma; Neuroendocrine tumours; SurgeryGallbladder Neuroendocrine Carcinomamedicine.medical_treatmentGallstonesAdenocarcinomaNeuroendocrine tumorsSettore MED/08 - Anatomia PatologicaDiagnosis Differential03 medical and health sciences0302 clinical medicineNeuroendocrine tumourmedicineCarcinomaHepatectomyHumansAgedIncidental Findingsbusiness.industryLarge cell neuroendocrine carcinomaGallbladderGeneral surgeryLiver NeoplasmsCarcinomaGallbladderGeneral MedicineGallstonesmedicine.diseaseCarcinoma NeuroendocrineNeuroendocrine TumorsSettore MED/18 - Chirurgia Generalemedicine.anatomical_structureCholecystectomy Laparoscopic030220 oncology & carcinogenesisNeuroendocrine carcinomaCarcinoma Large CellFemaleGallbladder Neoplasms030211 gastroenterology & hepatologySurgeryCholecystectomyRadiologyGallbladder NeoplasmDifferential diagnosisbusiness
researchProduct

ANCA-associated vasculitides: Recommendations of the French Vasculitis Study Group on the use of immunosuppressants and biotherapies for remission in…

2019

Treatment of vasculitides associated with anti-neutrophil cytoplasm antibodies (ANCA) (AAVs) has evolved dramatically in recent years, particularly since the demonstration of rituximab efficacy as remission induction and maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis. In 2013, the French Vasculitis Study Group (FVSG) published recommendations for its use by clinicians. Since then, new data have made it possible to better specify and codify prescription of rituximab to treat AAVs. Herein, the FVSG Recommendations Committee, an expert panel comprised of physicians with extensive experience in the treatment and management of vasculitides, presents its con…

medicine.medical_specialtyCardiologyAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisMaintenance Chemotherapy03 medical and health sciencesRemission induction0302 clinical medicineMaintenance therapymedicineHumans030212 general & internal medicineMedical prescriptionIntensive care medicineSocieties Medical030203 arthritis & rheumatologybusiness.industryRemission InductionGranulomatosis with PolyangiitisGeneral Medicinemedicine.diseaseBiological TherapyPractice Guidelines as TopicRituximabFranceGranulomatosis with polyangiitisbusinessMicroscopic polyangiitisVasculitisMepolizumabImmunosuppressive Agentsmedicine.drugLa Presse Médicale
researchProduct